Statin pretreatment and presentation patterns in patients with coronary artery disease

Cardiology Journal

Volumn 20, Issue 1, 2013, Pages 52-58

  Ndrepepa, Gjin ^a   Fusaro, Massimiliano ^a   King, Lamin ^a   Cassese, Salvatore ^a   Tada, Tomohisa ^a   Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute coronary syndrome; Angina; Atherosclerosis; Myocardial infarction; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GENSINI SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA, STABLE; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84873640229     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: 10.5603/CJ.2013.0009     Document Type: Article

References (35)

1. Ambrose JA, Tannenbaum MA, Alexopoulos D et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol, 1988; 12: 56-62.
2. Little WC, Constantinescu M, Applegate RJ et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mildto-moderate coronary artery disease? Circulation, 1988; 78: 1157-1166.
3. Hackett D, Davies G, Maseri A. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J, 1988; 9: 1317-1323.
4. Frobert O, van't Veer M, Aarnoudse W, Simonsen U, Koolen JJ, Pijls NH. Acute myocardial infarction and underlying stenosis severity. Catheter Cardiovasc Interv, 2007; 70: 958-965.
5. Manoharan G, Ntalianis A, Muller O et al. Severity of coronary arterial stenoses responsible for acute coronary syndromes. Am J Cardiol, 2009; 103: 1183-1188.
6. Ndrepepa G, Tada T, Fusaro M et al. Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol, 2012; 101: 1003-1011.
7. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994; 344: 1383-1389.
8. Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med, 1996; 335: 1001-1009.
9. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998; 339: 1349-1357.
10. Go AS, Iribarren C, Chandra M et al. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med, 2006; 144: 229-238.
11. Spencer FA, Allegrone J, Goldberg RJ et al. Association of statin therapy with outcomes of acute coronary syndromes: The GRACE study. Ann Intern Med, 2004; 140: 857-866.
12. Chia S, Raffel OC, Takano M, Tearney GJ, Bouma BE, Jang IK. Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study. Coron Artery Dis, 2008; 19: 237-242.
13. Otsuka F, Hibi K, Kusama I et al. Impact of statin pretreatment on the incidence of plaque rupture in ST-elevation acute myocardial infarction. Atherosclerosis, 2010; 213: 505-511.
14. Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation, 2000; 102: 118-122.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 1976; 16: 31-41.
16. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983; 51: 606.
17. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J, 1968; 75: 325-334.
18. Arnold SV, Spertus JA, Tang F et al. Statin use in outpatients with obstructive coronary artery disease. Circulation, 2011; 124: 2405-2410.
19. Davies MJ. The pathophysiology of acute coronary syndromes. Heart, 2000; 83: 361-366.
20. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart, 1999; 82: 265-268.
21. Burke AP, Kolodgie FD, Farb A et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation, 2001; 103: 934-940.
22. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation, 2012; 125: 1147-1156.
23. Inoue K, Motoyama S, Sarai M et al. Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. J Am Coll Cardiol Cardiovasc Imaging, 2010; 3: 691-698.
24. Takarada S, Imanishi T, Kubo T et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis, 2009; 202: 491-497.
25. Miyagi M, Ishii H, Murakami R et al. Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: A non-randomized study of the history of long-term statin treatment before coronary angioplasty. Clin Ther, 2009; 31: 64-73.
26. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA, 2006; 295: 1556-1565.
27. Reilly SD, Litovsky SH, Steinkampf MP, Caulfield JB. Statins improve human coronary atherosclerotic plaque morphology. Tex Heart Inst J, 2008; 35: 99-103.
28. Schartl M, Bocksch W, Koschyk DH et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation, 2001; 104: 387-392.
29. Rioufol G, Gilard M, Finet G, Ginon I, Boschat J, Andre-Fouet X. Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: Long-term follow-up with intravascular ultrasound. Circulation, 2004; 110: 2875-2880.
30. Zaman T, Agarwal S, Anabtawi AG et al. Angiographic lesion severity and subsequent myocardial infarction. Am J Cardiol, 2012; 110: 167-172.
31. Moran L, Fugate T, Xiang Y, Cianci C, Matsumura M. Statin pretreatment is protective despite an association with greater coronary artery disease burden in patients presenting with a first ST-elevation myocardial infarction. Prev Cardiol, 2008; 11: 21-25.
32. Neefjes LA, Ten Kate GJ, Rossi A et al. CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia. Heart, 2011; 97: 1151-1157.
33. Pourati I, Kimmelstiel C, Rand W, Karas RH. Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J, 2003; 146: 876-881.
34. Ndrepepa G, Mehilli J, Schulz S et al. Patterns of presentation and outcomes of patients with acute coronary syndromes. Cardiology, 2009; 113: 198-206.
35. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med, 2010; 362: 2155-2165.